Gender Differences in Association of Prescription Opioid Use and Mortality: A Propensity-Matched Analysis from the Reasons for Geographic and Racial Differences in Stroke (Regards) Prospective Cohort
Authors:
- 20 December 2019
- journal article
- research article
- Published by SAGE Publications in Substance Abuse
- Vol. 42 (1) , 94-103
Abstract
Background: Prescription opioids (PO) have been widely used for chronic non-cancer pain, with commensurate concerns for overdose. The long-term effect of these medications on non-overdose mortality in the general population remains poorly understood. This study's objective was to examine the association of prescription opioid use and mortality in a large cohort, accounting for gender differences and concurrent benzodiazepine use, and using propensity score matching. Methods: 29,025 US community-dwellers were enrolled in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort between 2003 and 2007, and followed through December 31, 2012. At baseline there were 1907 participants with PO; 1864 of them were matched to participants without PO, based on the model-derived propensity to receive opioid prescriptions. Causes of death were expert-adjudicated. Results: Over median follow-up of 6 years there were 4428 deaths (413 among persons with PO). The risk for all-cause mortality was 12% higher, in absolute terms, for persons with PO compared to those without PO in the overall sample, with gender differences (interaction p = .0008). The risk of death was increased for women with PO (hazard ratio [HR] 1.21 [95% Confidence Interval (CI) 1.04–1.40]), but not men (HR 0.92 [95% CI 0.77–1.10]). Women with PO were at higher risk of cardiovascular disease (CVD) death (HR 1.43 [95% CI 1.12–1.84]), sudden death (HR 2.02 [95% CI 1.29–3.15]) (a subset of CVD death), and accidents (HR 2.18 [95% CI 1.03–4.60]). These risks were not observed for men with PO. Conclusion: Over 6 years of follow-up, women but not men who had opioid prescriptions were at higher risk of all-cause mortality, CVD death, sudden death, and accidents. Special caution in prescribing opioids for women may be warranted until these findings are confirmed.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
- U.S. Department of Health and Human Services (R01 HL08477)
- U.S. Department of Health and Human Services (K24 HL111154)
- National Heart, Lung, and Blood Institute
This publication has 62 references indexed in Scilit:
- Perceived Stress Is Associated With Incident Coronary Heart Disease and All‐Cause Mortality in Low‐ but Not High‐Income Participants in the Reasons for Geographic And Racial Differences in Stroke StudyJournal of the American Heart Association, 2013
- Opioid use among low back pain patients in primary care: Is opioid prescription associated with disability at 6-month follow-up?Pain, 2013
- Sudden Cardiac Arrest in a Patient on Chronic Methadone After the Addition of AzithromycinThe American Journal of the Medical Sciences, 2013
- A prospective study of the impact of musculoskeletal pain and radiographic osteoarthritis on health related quality of life in community dwelling older peopleBMC Musculoskeletal Disorders, 2012
- Improving the Pharmacologic Management of Pain in Older Adults: Identifying the Research Gaps and Methods to Address ThemPain Medicine, 2011
- Primary care providers' perspective on prescribing opioids to older adults with chronic non-cancer pain: A qualitative studyBMC Geriatrics, 2011
- Matching Methods for Causal Inference: A Review and a Look ForwardStatistical Science, 2010
- Oxycodone is associated with dose‐dependent QTc prolongation in patients and low‐affinity inhibiting of hERG activity in vitroBritish Journal of Clinical Pharmacology, 2009
- Multiple imputation in health‐are databases: An overview and some applicationsStatistics in Medicine, 1991
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986